4 news items
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
VVOS
14 May 24
' strategy to add additional products across the price spectrum to its portfolio to diversify revenue opportunities beyond VIP enrollments. Revenue
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
VVOS
14 May 24
to implement additional revenue, sales and marketing strategies and other strategies aimed at increasing revenues, (ii) the risk that some patients may
Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
VVOS
9 Apr 24
herein or from other strategies aimed at increasing revenues, (ii) the risk that some patients may not achieve the desired results from using Vivos
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
VVOS
28 Mar 24
that Vivos may be unable to implement revenue, sales and marketing strategies and other strategies that increase revenues, (ii) the risk that some patients
- Prev
- 1
- Next